Attached files

file filename
EX-99.1 - PRESS RELEASE - Brooklyn ImmunoTherapeutics, Inc.ntn8k-ex9901.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 6, 2012

 
NTN BUZZTIME, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
     
001-11460
 
31-1103425
(Commission File Number)
 
(IRS Employer
Identification No.)
     
2231 Rutherford Road, Suite 200
Carlsbad, California
 
92008
(Address of Principal Executive Offices)
 
(Zip Code)
     
(760) 438-7400
(Registrant's telephone number, including area code)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 



 
 

 


Item 8.01.     Other Events.
 
On January 6, 2012, we issued a press release announcing a reduced subscription price for the planned rights offering to existing stockholders. A copy of the press release is included as an exhibit to this report and is incorporated herein by reference.
 
Item 9.01.     Financial Statements and Exhibits.
 
(d) Exhibits
 
99.1
Press Release dated January 6, 2012
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 


 

 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  
NTN BUZZTIME, INC.
     
Dated: January 6, 2012
By:
/s/ Kendra Berger
   
Kendra Berger
Chief Financial Officer

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 

EXHIBIT INDEX

Exhibit No.
Document
   
99.1
Press Release dated January 6, 2012